Aeon
Connecting Sign in

Every public trading filing, minutes after it lands, in plain words.

Get alerts

← Feed

IMMX

Immix Biopharma, Inc.

Alert me on IMMX
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

2
Sep 18, 2025 Buy Rachman Ilya M Insider
1 week
−2.4%S&P −0.4%
1 month
+37.3%S&P +0.6%
3 months
+166.0%S&P +1.7%
6 months
+335.9%S&P −1.2%
Sep 18, 2025 Buy Morris Gabriel S Insider
1 week
−2.4%S&P −0.4%
1 month
+37.3%S&P +0.6%
3 months
+166.0%S&P +1.7%
6 months
+335.9%S&P −1.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for IMMX 2 held · newest first
Loading the filings.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
NoneQ3 2025
NoneQ4 2025
$70KQ1 2026
$145KQ2 2026
Up 107 percent from Q1 2026. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov on Sep 23, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.